Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression
Pathology - Research and Practice · 2024-11 · 263 · 155652
DOI: 10.1016/j.prp.2024.155652 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024-11. Verfasst von Lakshmi Thangavelu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Indi…. Hauptthemen laut MEDLINE: Cellular Senescence, Liver Neoplasms, Tumor Suppressor Protein p53, Signal Transduction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 249 Literaturangaben.
Abstract (Originalsprache)
Liver cancer is a major health epidemic worldwide, mainly due to its high mortality rates and limited treatment options. The association of cellular senescence to tumorigenesis and the cancer hallmarks remains a subject of interest in cancer biology. The p53-p21 signalling axis is an important regulator in restoring the cell's balance by supporting tumor suppression and tumorigenesis in liver cancer. We review the novel molecular mechanisms that p53 and its downstream effector, p21, employ to induce cellular senescence, making it last longer, and halt the proliferation of damaged hepatocytes to become tumorous cells. We also examine how dysregulation of this pathway contributes to HCC pathogenesis, proliferation, survival, acquired resistance to apoptosis, and increased invasiveness. Furthermore, we comprehensively describe the molecular cross-talk between the p53-p21 signalling axis and major cell cycle signalling pathways, including Wnt/β-catenin, PI3K/Akt, and TGF-β in liver cancer and provide an overview of promising candidates for chemoprevention and future therapeutic strategies. This review article explores the roles of the p53-p21 pathway in liver cancer, examining its function in promoting cellular senescence under normal conditions and its potential role in cancer progression. It also highlights novel therapeutic drugs and drug targets within the pathway and discusses the implications for treatment strategies and prognosis in liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
- Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.
- Institute of Pharmaceutical Research, GLA UNIVERSITY, Mathura, UP 281406, India. Electronic address: babuphd2001@yahoo.co.in.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Department of Sciences, Vivekananda Global University, Jaipur, Rajasthan 303012, India.
Zitieren
APA
Thangavelu, L., Altamimi, A. S. A., Ghaboura, N., Babu, M. A., Roopashree, R., Sharma, P., Pal, P., Choudhary, C., Prasad, G. V. S., Sinha, A., Balaraman, A. K., & Rawat, S. (2024). Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression. Pathology - Research and Practice, 263, 155652. https://doi.org/10.1016/j.prp.2024.155652
Vancouver
Thangavelu L, Altamimi ASA, Ghaboura N, Babu MA, Roopashree R, Sharma P, et al. Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression. Pathology - Research and Practice. 2024;263:155652. doi:10.1016/j.prp.2024.155652
BibTeX
@article{Thangavelu2024,
author = {Thangavelu, Lakshmi and Altamimi, Abdulmalik S A and Ghaboura, Nehmat and Babu, M Arockia and Roopashree, R and Sharma, Pawan and Pal, Pusparghya and Choudhary, Chhavi and Prasad, G V Siva and Sinha, Aashna and Balaraman, Ashok Kumar and Rawat, Sushama},
title = {Targeting the p53-p21 axis in liver cancer: Linking cellular senescence to tumor suppression and progression},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {263},
pages = {155652},
doi = {10.1016/j.prp.2024.155652}
}
EUVIMED